CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 

Panbela Therapeutics Inc 's Tangible Leverage Ratio

PBLA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




PBLA Tangible Leverage Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Tangible Equity Change -61.48 % - - - -13.23 %
Y / Y Total Liabilities Change 209.3 % 427.33 % 881.78 % 718.02 % 244.05 %
Tangible Leverage Ratio MRQ 5.5 - - - 0.68
Overall Ranking # 2465 # # # # 1607
Seq. Tangible Equity Change - - - - -35.56 %
Seq. Total Liabilities Change -0.62 % 6.7 % 15.37 % 152.83 % 69.44 %

New: More PBLA's historic Tangible Leverage Ratio results >>


Comment on PBLA Tangible Leverage Ratio in the first quarter 2023
In Spite of the repayements of liabilities of -0.62%, in I Quarter 2023 ,Tangible Leverage Ratio deteriorated to 5.5, above the company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the first quarter 2023, 365 other companies have achieved lower Tangible Leverage Ratio than Panbela Therapeutics Inc in the I Quarter 2023. While total ranking remained the same in the first quarter 2023 compared to the previous quarter at no. .

Explain Tangible Leverage Ratio?
What is PBLA Market Share?
What are PBLA´s Total Liabilities?
Tangible Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 366
Healthcare Sector # 709
Overall Market # 2462


Tangible Leverage Ratio Statistics
High Average Low
13.1 2.51 0.1
(Jun 30 2018)   (Sep 30 2021)




Financial Statements
Panbela Therapeutics Inc 's Tangible Equity $ 3 Millions Visit PBLA's Balance sheet
Panbela Therapeutics Inc 's Total Liabilities $ 14 Millions Visit PBLA's Balance sheet
Source of PBLA's Sales Visit PBLA's Sales by Geography


Cumulative Panbela Therapeutics Inc 's Tangible Leverage Ratio

PBLA's Tangible Leverage Ratio for the trailling 12 Months

PBLA Tangible Leverage Ratio

 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Tangible Equity TTM Growth -61.48 % - - - -13.23 %
Y / Y Total Liabilities TTM Growth 209.3 % 427.33 % 881.78 % 718.02 % 244.05 %
Tangible Leverage Ratio TTM - - 8.63 0.78 0.27
Total Ranking TTM # 1707 # 0 # 3620 # 1485 # 613
Seq. Tangible Equity TTM Growth - - - - -35.56 %
Seq. Total Liabilities TTM Growth -0.62 % 6.7 % 15.37 % 152.83 % 69.44 %

PBLA Company Profile >> Back to PBLA Financial Strength Comparisons >> See PBLA Balance Sheets

TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of -0.62% in the trailling twelve months ending in I Quarter 2023, Tangible Leverage Ratio decreased to -2.82, below Panbela Therapeutics Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 365, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Panbela Therapeutics Inc . While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2023, compared to the prior period, from 0 to 1707.

Explain Tangible Leverage Ratio?
What is PBLA Market Share?
What are PBLA´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 366
Healthcare Sector # 709
Within the Market # 2462


TTM Tangible Leverage Ratio Statistics
High Average Low
13.1 2.51 0.1
(Jun 30 2018)   (Sep 30 2021)




Companies with similar Tangible Leverage Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioMar 31 2023 MRQ Total LiabilitiesMar 31 2023 MRQ Tangible Equity
Lifecore Biomedical Inc   12.68 $ 201.946  Millions$ 15.926  Millions
Pfizer Inc  11.84 $ 91,830.000  Millions$ 7,758.000  Millions
Ocean Biomedical Inc   10.92 $ 16.865  Millions$ 1.544  Millions
Ocular Therapeutix Inc   10.03 $ 97.408  Millions$ 9.711  Millions
Pacira Biosciences inc   9.61 $ 755.377  Millions$ 78.574  Millions
Ani Pharmaceuticals inc  9.46 $ 450.592  Millions$ 47.620  Millions
Cumberland Pharmaceuticals Inc   8.43 $ 48.401  Millions$ 5.744  Millions
Supernus Pharmaceuticals inc   7.81 $ 879.658  Millions$ 112.634  Millions
Societal Cdmo Inc   7.27 $ 88.394  Millions$ 12.155  Millions
Abbott Laboratories  6.83 $ 29,367.000  Millions$ 4,299.000  Millions
Omeros Corporation  6.56 $ 360.400  Millions$ 54.936  Millions
Intercept Pharmaceuticals inc   6.50 $ 436.900  Millions$ 67.185  Millions
Axsome Therapeutics Inc   6.39 $ 277.367  Millions$ 43.413  Millions
Tg Therapeutics inc   6.00 $ 159.846  Millions$ 26.634  Millions
Orgenesis Inc   5.59 $ 64.264  Millions$ 11.504  Millions
Panbela Therapeutics Inc   5.50 $ 13.940  Millions$ 2.535  Millions
Veru Inc   5.47 $ 53.538  Millions$ 9.795  Millions
Maravai Lifesciences Holdings Inc   5.40 $ 1,793.871  Millions$ 332.491  Millions
Dar Bioscience Inc   5.11 $ 25.395  Millions$ 4.972  Millions
Ionis Pharmaceuticals Inc   4.93 $ 2,398.651  Millions$ 486.570  Millions
Horizon Therapeutics Public Limited Company  4.91 $ 3,429.118  Millions$ 698.859  Millions
Abvc Biopharma Inc   4.82 $ 8.353  Millions$ 1.735  Millions
Emergent Biosolutions Inc   4.65 $ 1,747.200  Millions$ 375.500  Millions
Durect Corp  4.59 $ 42.086  Millions$ 9.173  Millions
China Pharma Holdings Inc   4.46 $ 12.687  Millions$ 2.843  Millions
Pieris Pharmaceuticals Inc   4.32 $ 66.800  Millions$ 15.458  Millions
Opko Health Inc   4.10 $ 617.860  Millions$ 150.814  Millions
Phibro Animal Health Corporation  3.82 $ 618.984  Millions$ 162.184  Millions
Timber Pharmaceuticals Inc   3.79 $ 4.966  Millions$ 1.311  Millions
Evoke Pharma Inc   3.68 $ 7.822  Millions$ 2.126  Millions

Date modified: 2023-05-05T20:49:15+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071